Clinical Trial Update: Effectiveness of iPRF Injections in Temporomandibular Joints Degeneration Management [Phase 2, Phase 3]

View source ↗

Summary

Phase 2/Phase 3 clinical trial evaluating the effectiveness of injectable platelet-rich fibrin (iPRF) injections in temporomandibular joint degeneration.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Temporomandibular Disorders
• Temporomandibular Joint Arthritis
• Temporomandibular Joint Disorders
• Temporomandibular Joint Osteoarthritis

Drugs mentioned

• iPRF injections (platelet-rich fibrin (PRF))

Snippet

Sponsor: Wroclaw Medical University | Conditions: Temporomandibular Disorder, Temporomandibular Joint Disorders | Phase 2, Phase 3 | Status: ENROLLING_BY_INVITATION